Near-Infrared Light Therapy Combined With Lecanemab for Mild Alzheimer's Disease

Clinical trial NCT06992804 · RECRUITING

Trial details

NCT number: NCT06992804
Sponsor: Xuanwu Hospital, Beijing
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2025-05-28
Primary completion: 2025-10-15
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.